AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Apr 16, 2021
29821_dirs_2021-04-16_8252fb20-7751-4efa-811f-9850e23e436d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-04-15
Reporting Person: Mirviss Jeffrey B. (EVP&Pres, Periph Intervent)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-15 | Common Stock | M | 28123.0000 | $6.2800 | Acquired | 167281.0000 | Direct |
| 2021-04-15 | Common Stock | S | 28123.0000 | $40.9501 | Disposed | 139158.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-15 | Stock Option (Right to Buy) | $6.2800 | M | 28123.0000 | Disposed | 2022-02-27 | Common Stock (28123.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at $40.95 and $40.955. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase 28,123 shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.